Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
Trabectedin is the first marine-derived anti-neoplastic drug approved for the treatment of advanced soft tissue sarcoma and, in combination with pegylated liposomal doxorubicin, for the treatment of patients with relapsed platinum-sensitive ovarian cancer. From the beginning of its development, trab...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Revisão |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2014
|
| Sarrera elektronikoa: | https://doi.org/10.1038/bjc.2014.149 https://www.nature.com/articles/bjc2014149.pdf |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|